Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07757841 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Real-World Effectiveness of Tezepelumab in Allergic Bronchopulmonary Aspergillosis

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
An open-label study will evaluate effects of Tezepelumab in the treatment of severe asthma in patients with allergic bronchopulmonary aspergillosis
Trial Details
NCT Number NCT07757841
Lead Sponsor Qianfoshan Hospital
Conditions
(from sponsor)		 Allergic Bronchopulmonary Aspergillosis, Severe Asthma, ABPA
Related terms Aspergillosis, Allergic Bronchopulmonary, Asthma
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov